Heart Failure
Conditions
Brief summary
The aim of this study is to evaluate sit-stand phases and gait speed detection using an externally worn Reveal LINQ (TM) compared to an external reference (3D accelerometer, and/or the Computer Assisted Rehabilitation Environment (CAREN) system) in one center in the Netherlands
Detailed description
Frailty is a geriatric syndrome characterized by reduced homeostatic reserves, exposing the organism to extreme vulnerability to endogenous and exogenous stressors. Frailty is prevalent in older people and involves a progressive physiological decline of multiple body systems, typical signs and symptoms include weight loss, fatigue, muscle weakness, slow or unsteady gait declines in activity. Frailty is increasingly recognized as an important prognostic indicator in heart failure (HF) and is more prevalent in HF than the general population. The identification of frailty in its early stage is important because interventions may potentially prevent, or delay the clinical consequences of frailty. Of particular focus in this study will be walking speed as prior research has demonstrated that slow gait speed has the strongest prognostic ability of the traditional components used to assess frailty, and has been reported as one of the strongest to predict adverse outcomes, such as mobility disability, falls, or hospitalization. Also of interest is the detection of posture changes as this may have implications for detecting changes in sleeping habits and could also provide context for other biomarker signals collected by the LINQ device. The literature has been reviewed and the scientific soundness of the proposed analytical techniques evaluated. The rationale for this study design is to evaluate the feasibility of using the Reveal LINQ™ to monitoring walking patterns. HF patients (the target population for the study in discussion) would make it possible to test the sensitivity of the accelerometer embedded in the LINQ device in a small cohort of subjects with reduced mobility and for which frailty is more prevalent than the general population, as well as recognized as an important prognostic indicator. No risk to the subjects is expected with this study.
Interventions
The Six Minute Walk (6MW) Test measures the distance an individual is able to walk over a total of six minutes on a flat surface. The goal is for the individual to walk as far as possible in six minutes. The Six Minute Walk (6MW) test will be performed within the Computer Assisted Rehabilitation Environment (CAREN) system system environment - single arm
The 4 Meter Gait Speed (4MGS) Test measures the gait speed an individual is able to walk over 4 meters on a flat surface. The goal is for the individual to walk as fast as possible over 4 meters. It will be repeated 3 times within the aforementioned 6MW test (after approximately 1, 3 and 5 minutes) to get variability due to subject tiredness. The test will be performed within the CAREN system environment. - single arm
The Five Times Sit to Stand (FTSTS) Test measures the time a subject takes to stand up from an armchair 5 times in a row, without stopping in between. It is a short test which measures dynamic balance and functional mobility - single arm
The Expanded Timed Get-Up-and-Go (ETGUG) Test measures the time it takes a subject to stand up from an armchair, walk a distance of 10 m, turn, walk back to the chair, and sit down. It is a short test of basic mobility skills for frail community-dwelling elderly. - single arm
Walking exercises test
Walking exercises test
Sponsors
Study design
Eligibility
Inclusion criteria
* Chronic Heart Failure in New York Heart Association (NHYA) class II and class III * Willing to sign the informed consent form. * At least 18 years of age.
Exclusion criteria
* • Not able to walk continuously for a period of 6 minutes and perform the walking exercises as necessary for the study protocol. * Any known allergy to Titanium * Any concomitant conditions which in the opinion of the investigator would not allow accurate measurement of gait and frailty parameters with an externally worn device. * Any concomitant condition which in the opinion of the investigator would not allow a safe participation in the study. * Enrolled in another study that could confound the results of this study, without documented pre-approval from a Medtronic study manager.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Correlation of Gait Speed Between Reveal LINQ Accelerometer, Validation Accelerometer and/or Computer Assisted Rehabilitation System by Walking Exercises | During walking exercises visit, 1 Day | The gait speed will be calculated from the Reveal LINQ accelerometer signals, from the validation accelerometer and / or from the computer assisted rehabilitation system during the walking exercises. We will calculate the average correlation coefficient over all patients and exercises. It is reported as score on a scale, with minimum value= -1 and maximum value = 1. Higher absolute values mean higher correlation. |
Countries
Netherlands
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| All Study Participants Patients with Chronic Heart Failure. No control group has been used for this study, but all the patients enrolled will perform the same walking exercises.
On arrival to the rehabilitation center, subjects will have the Reveal LINQ, the 3D-accelerometers (one on the chest by medical-grade adhesives and a second at the level of the waist over the top of a medical grade adhesive) and the Holter attached externally. Then, they will be asked to perform the following exercises:
* Walking exercises - Six Minute Walk (6MW) Test
* Walking exercises - 4 Meter Gait Speed (4MGS) Test
* Walking Exercises - Five Times Sit to Stand (FTSTS) Test
* Walking Exercises - Expanded Timed Get-Up-and-Go (ETGUG) Test | 15 |
| Total | 15 |
Baseline characteristics
| Characteristic | All Study Participants | — |
|---|---|---|
| Age, Categorical <=18 years | 0 Participants | — |
| Age, Categorical >=65 years | 10 Participants | — |
| Age, Categorical Between 18 and 65 years | 5 Participants | — |
| Race and Ethnicity Not Collected | — | — Participants |
| Region of Enrollment Netherlands | 15 participants | — |
| Sex: Female, Male Female | 4 Participants | — |
| Sex: Female, Male Male | 11 Participants | — |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 0 |
| other Total, other adverse events | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 |
Outcome results
Correlation of Gait Speed Between Reveal LINQ Accelerometer, Validation Accelerometer and/or Computer Assisted Rehabilitation System by Walking Exercises
The gait speed will be calculated from the Reveal LINQ accelerometer signals, from the validation accelerometer and / or from the computer assisted rehabilitation system during the walking exercises. We will calculate the average correlation coefficient over all patients and exercises. It is reported as score on a scale, with minimum value= -1 and maximum value = 1. Higher absolute values mean higher correlation.
Time frame: During walking exercises visit, 1 Day
Population: 15 subjects were enrolled and completed the study. All subjects met the inclusion and exclusion criteria.~One subject did not have readable device data and as such was excluded from the analysis.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Correlation Coefficient - Six Minute Walk (6MW) Test | Correlation of Gait Speed Between Reveal LINQ Accelerometer, Validation Accelerometer and/or Computer Assisted Rehabilitation System by Walking Exercises | Correlation per each Exercise | 0.97 Correlation Coefficient |
| Correlation Coefficient - Six Minute Walk (6MW) Test | Correlation of Gait Speed Between Reveal LINQ Accelerometer, Validation Accelerometer and/or Computer Assisted Rehabilitation System by Walking Exercises | Average Correlation Across All Exercises | 0.91 Correlation Coefficient |
| Correlation Coefficient - 4 Meter Gait Speed (4MGS) Test | Correlation of Gait Speed Between Reveal LINQ Accelerometer, Validation Accelerometer and/or Computer Assisted Rehabilitation System by Walking Exercises | Average Correlation Across All Exercises | 0.91 Correlation Coefficient |
| Correlation Coefficient - 4 Meter Gait Speed (4MGS) Test | Correlation of Gait Speed Between Reveal LINQ Accelerometer, Validation Accelerometer and/or Computer Assisted Rehabilitation System by Walking Exercises | Correlation per each Exercise | 0.93 Correlation Coefficient |
| Correlation Coefficient - Five Times Sit to Stand (FTSTS) Test | Correlation of Gait Speed Between Reveal LINQ Accelerometer, Validation Accelerometer and/or Computer Assisted Rehabilitation System by Walking Exercises | Correlation per each Exercise | 0.86 Correlation Coefficient |
| Correlation Coefficient - Five Times Sit to Stand (FTSTS) Test | Correlation of Gait Speed Between Reveal LINQ Accelerometer, Validation Accelerometer and/or Computer Assisted Rehabilitation System by Walking Exercises | Average Correlation Across All Exercises | 0.91 Correlation Coefficient |
| Correlation Coefficient - ETGUG Test | Correlation of Gait Speed Between Reveal LINQ Accelerometer, Validation Accelerometer and/or Computer Assisted Rehabilitation System by Walking Exercises | Correlation per each Exercise | 0.91 Correlation Coefficient |
| Correlation Coefficient - ETGUG Test | Correlation of Gait Speed Between Reveal LINQ Accelerometer, Validation Accelerometer and/or Computer Assisted Rehabilitation System by Walking Exercises | Average Correlation Across All Exercises | 0.91 Correlation Coefficient |